Form 4: KORU Medical Director Manko Acquires Shares
Insider Transaction Report
Joseph M. Manko, Jr., a Director and 10% owner of KORU Medical Systems, Inc., acquired 3,916 shares of common stock as compensation for his board service.
Summary
- Joseph M. Manko, Jr., a Director and 10% owner of KORU Medical Systems, Inc. (KRMD), reported an acquisition of common stock.
- On September 30, 2025, Horton Capital Partners Fund, LP (HCPF) was granted 3,916 shares of KORU Medical Systems, Inc. common stock.
- These shares were granted as consideration for Mr. Manko's service as a Director for the quarter ended September 30, 2025.
- Following this transaction, HCPF indirectly beneficially owns 5,871,335 shares of KORU Medical Systems, Inc. common stock.
- The filing is a joint report by Joseph M. Manko, Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, L.P., all of whom are 10% owners.
Sentiment
Score: 6
Explanation: The filing reports a routine grant of shares as director compensation, which is a standard practice and aligns the director's interests with shareholders.
Positives
- A director received equity compensation, aligning management's interests with shareholders.
Risks
- Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest, and the filing is not an admission of beneficial ownership for Section 16 purposes or a legal requirement.
Future Outlook
NA
Management Comments
- The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
- Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein.
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Joseph M. Manko, Jr. received 3,916 shares of common stock as compensation for his service as a Director for the quarter ended September 30, 2025. | 09/30/2025 | Aligns director's financial interests with the company's performance and shareholder value. |
Related Party Transactions
- Horton Capital Partners Fund, LP, an entity related to Director Joseph M. Manko, Jr., received 3,916 shares of common stock as compensation for Mr. Manko's director service.
Stakeholder Impact
- Shareholders: Increased alignment of a significant shareholder/director with the company's long-term performance through equity compensation.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of transaction where Horton Capital Partners Fund, LP was granted 3,916 shares of common stock. |
| 09/30/2025 | End of the quarter for which Mr. Manko's director service was compensated. |
| 10/02/2025 | Date of signatures for the Form 4 filing. |
Recommendation
holdThis Form 4 filing details a routine grant of shares as compensation for director service, which is a standard practice and does not provide new information that would significantly alter the investment thesis for KORU Medical Systems, Inc. It indicates continued alignment of a key insider's interests with the company's performance but does not suggest a change in fundamental value or outlook.
Keywords
KORU Medical Systems, KRMD, insider transaction, Form 4, director compensation, stock acquisition, beneficial ownership, Horton Capital
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.